DocSym
β
Searchsearch
Search
(C92.5) Acute myelomonocytic leukaemia
More details coming soon
2 243 317 in individuals diagnosis acute myelomonocytic leukaemia confirmed
425 448 deaths with diagnosis acute myelomonocytic leukaemia
19% mortality rate associated with the disease acute myelomonocytic leukaemia
Diagnosis acute myelomonocytic leukaemia is diagnosed Men are 6.82% more likely than Women
1 198 186
Men receive the diagnosis acute myelomonocytic leukaemia
238 642 (19.9 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
1 045 131
Women receive the diagnosis acute myelomonocytic leukaemia
186 806 (17.9 %)Died from this diagnosis.
Risk Group for the Disease acute myelomonocytic leukaemia - Men aged 55-59 and Women aged 65-69
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any agein in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features acute myelomonocytic leukaemia
Absence or low individual and public risk
Acute myelomonocytic leukaemia - what does this mean
Acute myelomonocytic leukaemia (aml-m4) is a type of blood cancer that starts in the bone marrow, where blood cells are made. it is caused by a genetic mutation that results in the overproduction of immature myeloid cells, which can interfere with the production of healthy blood cells. this can lead to anemia, infections, and other health problems.
What happens during the disease - acute myelomonocytic leukaemia
Acute myelomonocytic leukaemia (aml-m4) is a type of blood cancer that affects the bone marrow and other blood-forming organs. it is caused by a genetic mutation that leads to the production of abnormal white blood cells called myelomonocytes. these cells accumulate in the bone marrow and other parts of the body, leading to an increased number of immature white blood cells, which can interfere with the production of healthy red and white blood cells. as a result, individuals with aml-m4 may experience symptoms such as fatigue, anemia, and increased risk of infection.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete Blood Count (CBC)
- Bone Marrow Aspiration and Biopsy
- Flow Cytometry
- Cytogenetic Analysis
- Molecular Testing
- Immunophenotyping
Treatment and Medical Assistance
Main Goal: To reduce the symptoms of acute myelomonocytic leukaemia and increase the patient's quality of life.
- Chemotherapy
- Radiation therapy
- Stem cell transplants
- Targeted therapy
- Immunotherapy
- Surgery
- Clinical trials
- Pain management
- Nutritional support
24 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Acute myelomonocytic leukaemia - Prevention
Acute myelomonocytic leukaemia can be prevented by avoiding exposure to radiation and certain chemicals, such as benzene, and by maintaining a healthy lifestyle with a balanced diet and regular exercise. it is also important to avoid smoking and to limit alcohol consumption. vaccines may be available for some types of leukaemia, so it is important to consult with a medical professional to determine if any are recommended.